Sun Pharma's bid for Organon under review in Australia
MLex Summary: India-based pharmaceutical company Sun Pharma’s proposed acquisition of US-based Organon is under review by Australia's competition watchdog. The Australian Competition & Consumer Commission on Thursday said the companies overlap in...To view the full article, register now.
Already a subscriber? Click here to view full article